Study APV20002 Safety and Efficacy Results Through weeek 684 for Pediatric Participants Living with HIV1 Treated with RitonavirBoosted Fosamprenavir Oral SolutionsBased Antiretroviral Therapy

Simple item page
dc.article.end-page617en
dc.article.start-page606en
dc.citation.doi10.1089/AID.2024.0020en
dc.contributor.authorLisa Rossen
dc.contributor.authorM Cottonen
dc.contributor.authorHaseena Cassimen
dc.contributor.authorHarmony P Gargesen
dc.contributor.authorSven C van Dijkmanen
dc.contributor.authorE et alen
dc.date.accessioned2024-11-13T13:41:37Z
dc.date.available2024-11-13T13:41:37Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0889-2229en
dc.identifier.urihttps://hdl.handle.net/10539/42445
dc.journal.titleStudy APV20002 Safety and Efficacy Results Through weeek 684 for Pediatric Participants Living with HIV1 Treated with RitonavirBoosted Fosamprenavir Oral SolutionsBased Antiretroviral Therapyen
dc.journal.volume40en
dc.publisherMARY ANN LIEBERT, INCen
dc.school1.02en
dc.titleStudy APV20002 Safety and Efficacy Results Through weeek 684 for Pediatric Participants Living with HIV1 Treated with RitonavirBoosted Fosamprenavir Oral SolutionsBased Antiretroviral Therapyen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
533.52 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)